News

On October 28, New Jersey Governor Phil Murphy issued an Executive Order addressing health and safety requirements for New Jersey employers that require or permit their workers to be physically present in the office.

As coronavirus cases continue to surge across the United States and the Commonwealth of Kentucky, wary employers are revising their policies and response plans to mitigate against potential outbreaks in the workplace.

If you are a patent owner facing an inter partes review (“IPR”) or other post-grant review at the Patent Trial and Appeal Board (“PTAB”), your best chance of success is to convince the PTAB not to institute a trial.

On Wednesday, September 30, 2020, the Department of Justice (DOJ), along with the Federal Bureau of Investigation (FBI), Department of Health and Human Services Office of Inspector General (HHS-OIG), and the Drug Enforcement Administration (DEA) announced enforcement actions involving 345 individ

November 2020 Interest Rates for GRATs, Sales to Defective Grantor Trusts, Intra-Family Loans and Split Interest Charitable Trusts AFRs - Certain federal interest rates increased slightly for November of 2020, while others remained the same.

Are cannabis laws in your jurisdiction pretty well settled or are they constantly changing in material ways? Overall, cannabis laws are not well settled and may evolve from time to time. However, relevant regulations in Yunnan Province are quite settled. ...

Recently, the Internal Revenue Service has acknowledged that a computer program issue caused the erroneous revocation of tax-exemption for thousands of nonprofits across the country.  This statement from the IRS followed a letter from the Committee on Ways and Means to Secretary Mnuchin, inquirin

Governors and public health officials across the country have implemented stringent measures to help contain the spread of COVID-19, such as safer at home and face covering mandates. Some jurisdictions also require employers to screen the health of employees, often as they begin a shift....

The European Medicines Agency (“EMA”) and the EU network of Health Technology Assessment (“HTA”) bodies are jointly reviewing a proposed framework for patient preference studies.

Pages